Source comparison
Tesamorelin Dosing: A Comparison of Approaches
To make this easier to visualize, we've broken down a few common dosing strategies into a table. This is a simplified framework, but it provides a clear overview of how different protocols are structured. Standard Monotherapy 1mg – 2mg Pre-bed 12-26 Weeks Well
This comparison does not assign a generated winner or score.
- To make this easier to visualize, we've broken down a few common dosing strategies into a table. This is a simplified framework, but it provides a clear overview of how different protocols are structured.
- Standard Monotherapy
- 1mg – 2mg
- Pre-bed
- 12-26 Weeks
- Well-documented, straightforward protocol based on clinical data.
- Higher doses can increase the risk of side effects like fluid retention.
- Titration Protocol
- Start 500mcg, increase to 1mg+
- Minimizes initial side effects, allows for tolerance assessment.
- Slower onset of full effects; requires more careful monitoring initially.
- Synergistic Stack
- 500mcg-1mg Tesamorelin + 200-500mcg Ipamorelin
- 12-20 Weeks
- Potentially greater GH pulse with lower doses of each peptide. More natural release pattern.
- More complex protocol with two compounds to manage and measure.
- Pulsed Dosing
- Pre-bed, 5 days on / 2 days off
- 16-26 Weeks+
- May help maintain pituitary sensitivity over very long-term studies.
- Less data available on this approach; may slightly slow cumulative results.